Leith Wheeler Investment Counsel Ltd. Raises Holdings in Humana Inc. $HUM

Key Points

• Leith Wheeler Investment Counsel Ltd. increased its stake in Humana Inc. by 661.7% during the 2nd quarter, now owning 1,038,703 shares, which accounts for 14.9% of its investment portfolio.
• Institutional investors now hold approximately 92.38% of Humana's stock, with several firms recently increasing their stakes or acquiring new positions.
• Humana announced a quarterly dividend of $0.885 per share, representing an annualized yield of 1.3% and a payout ratio of 27.17%.

Leith Wheeler Investment Counsel Ltd. increased its stake in Humana Inc. (NYSE:HUM - Free Report) by 661.7% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,038,703 shares of the insurance provider's stock after purchasing an additional 902,340 shares during the quarter. Humana makes up 14.9% of Leith Wheeler Investment Counsel Ltd.'s investment portfolio, making the stock its largest holding. Leith Wheeler Investment Counsel Ltd. owned approximately 0.86% of Humana worth $253,942,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HUM. Revolve Wealth Partners LLC acquired a new stake in Humana in the 4th quarter worth approximately $202,000. GAMMA Investing LLC lifted its holdings in Humana by 54.9% in the 1st quarter. GAMMA Investing LLC now owns 2,952 shares of the insurance provider's stock worth $781,000 after purchasing an additional 1,046 shares during the last quarter. Assenagon Asset Management S.A. lifted its holdings in Humana by 8.2% in the 1st quarter. Assenagon Asset Management S.A. now owns 5,378 shares of the insurance provider's stock worth $1,423,000 after purchasing an additional 409 shares during the last quarter. CX Institutional bought a new position in Humana in the 1st quarter worth approximately $213,000. Finally, Fifth Third Bancorp increased its position in Humana by 14.4% in the 1st quarter. Fifth Third Bancorp now owns 8,228 shares of the insurance provider's stock worth $2,177,000 after buying an additional 1,034 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the company. Morgan Stanley dropped their price target on Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a research report on Thursday, July 31st. Wolfe Research lifted their price target on Humana from $283.00 to $313.00 and gave the stock an "outperform" rating in a research report on Monday, October 6th. Sanford C. Bernstein lifted their price target on Humana from $269.00 to $341.00 and gave the stock an "outperform" rating in a research report on Friday, September 5th. Mizuho lifted their price target on Humana from $300.00 to $345.00 and gave the stock an "outperform" rating in a research report on Thursday. Finally, Piper Sandler dropped their price target on Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a research report on Thursday, July 31st. Eight equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $298.83.

Humana Stock Performance

HUM opened at $280.24 on Monday. The stock has a market cap of $33.71 billion, a PE ratio of 21.51, a P/E/G ratio of 1.64 and a beta of 0.42. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $315.35. The stock's 50 day simple moving average is $279.45 and its 200-day simple moving average is $258.04.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The firm had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The business's revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. Sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Friday, September 26th. Humana's dividend payout ratio is 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.